Daniel Loeb’s CVS Health CVS Stock Holding History

Daniel Loeb’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,575,000	Closed	-$99M	–	48
2024 Q3	$99M	Buy	+1,575,000	New	+$91.9M	1.33%	25

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Daniel Loeb's CVS Position: Q4 2024 in Review

Daniel Loeb sold out of CVS Health (CVS) in Q4 2024, closing a stake of 1,575,000 shares — an estimated $99M sold.

Daniel Loeb first reported a position in CVS in Q3 2024 and held it in 1 quarter. The position peaked at $99M in Q3 2024. 1,670 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

Daniel Loeb reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
Daniel Loeb sold 1,575,000 CVS Health shares in Q4 2024, an estimated $99M.
Daniel Loeb first reported a position in CVS Health in Q3 2024 and held it in 1 quarter.
Daniel Loeb's CVS Health position peaked at $99M in Q3 2024.
1,670 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Third Point's 13F filing for Q4 2024, filed 14 Feb 2025.